As a world-famous manufacturer of steroidal hormone pharmaceuticals and a leading domestic producer of amino acid APIs, Tianjin Pharmaceutical Holdings fully displayed its overall international development layout and comprehensive strengths at the exhibition. The company set up three exclusive booths for the Export Department of the API Center, Finished Dosage Sales Department of Xinzhuo International Trade, and Hubei Tianjin Pharmaceutical, showcasing its latest achievements in integrated API and finished dosage development, industrial deployment and global business expansion.

During the event, the company held in-depth discussions with worldwide partners covering core themes such as coordinated industrial chain planning, transnational capacity division, overseas registration of finished drugs, end-user channel expansion and compliant operation in global markets. Multiple letters of intent for cooperation were signed, further expanding the scope of international collaboration.

Participation in this exhibition has further clarified the roadmap for the coordinated overseas expansion of APIs and finished dosage forms, and strengthened the company’s confidence and capabilities in global development.

Moving forward, Tianjin Pharmaceutical Holdings will continue to deepen its presence in the core sectors of steroidal hormones and amino acid APIs, seize opportunities for finished product exports, steadily upgrade its global business layout, and consistently enhance its core competitiveness and brand influence across the world.